Defective LARGE does not transfer Xyl from UDP-Xyl to GlcA

Stable Identifier
R-HSA-6785668
Type
Reaction [transition]
Species
Homo sapiens
Compartment
cytosol, Golgi membrane
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Defective LARGE does not transfer Xyl from UDP-Xyl to GlcA
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Glycosyltransferase-like protein LARGE (MIM:603590) is a bifunctional glycosyltransferase with both xylosyltransferase and beta-1,3-glucuronyltransferase activities involved in the biosynthesis of a phosphorylated O-mannosyl trisaccharide, a structure present in alpha-dystroglycan (DAG1; MIM:128239) which plays a key role in skeletal muscle function and regeneration. LARGE contains two substrate-specific GT-domains and belongs to the CAZy glycosyltransferase families GT8 and GT49. Defects in LARGE result in hypoglycosylation of DAG1 and cause several congenital muscular dystrophies (CMDs). Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A6 (MDDGA6; MIM:613154) is associated with brain anomalies, eye malformations, profound mental retardation, and death usually in the first years of life (Clement et al. 2008, Mercuri et al. 2009). Muscular dystrophy-dystroglycanopathy congenital with mental retardation B6 (MDDGB6; MIM:608840) is associated with profound mental retardation, white matter changes and structural brain abnormalities (Longman et al. 2003). Several mutations are known (MIM:603590) and include W495R and S331F (Clement et al. 2008, Mercuri et al. 2009).
Literature References
PubMed ID Title Journal Year
19299310 Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study

Scuderi, C, Mottarelli, E, Morandi, L, Laverda, A, Saredi, S, Moggio, M, Biancheri, R, Pichiecchio, A, Berardinelli, A, Ruggieri, A, Pane, M, Toscano, A, Pegoraro, E, Messina, S, Boffi, P, Uggetti, C, Tessa, A, Santorelli, FM, Ricci, E, Comi, GP, Pini, A, Mercuri, E, Bertini, E, Trevisan, CP, Vasco, G, D'Amico, A, Mongini, T, Moroni, I, Bruno, C, Tortorella, G, Minetti, C, Aiello, C, Pezzani, R, Mora, M, Cassandrini, D

Neurology 2009
19067344 Brain involvement in muscular dystrophies with defective dystroglycan glycosylation

Talim, B, Smith, J, Rutherford, M, Abbs, S, Cowan, F, Godfrey, C, Clement, E, Kinali, M, Barkovich, AJ, Bushby, K, Manzur, A, Muntoni, F, Mercuri, E, Quinlivan, R, North, K, Klein, A, Mein, R, Straub, V, Longman, C, Topaloglu, H, McWilliam, R, Robb, S

Ann. Neurol. 2008
12966029 Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan

Merlini, L, Brown, SC, Kennedy, C, Brockington, M, Torelli, S, Muntoni, F, Feng, L, Voit, T, Sewry, CA, Saran, RK, Khalil, N, Jimenez-Mallebrera, C, Longman, C

Hum. Mol. Genet. 2003
Participants
Input
Participates
as an event of
Catalyst Activity

UDP-xylosyltransferase activity of B4GAT1:LARGE mutants [Golgi membrane]

Physical Entity
B4GAT1:LARGE mutants [Golgi membrane] (Homo sapiens)
Activity
UDP-xylosyltransferase activity (GO:0035252)
Normal reaction
B4GAT1:LARGE transfers Xyl from UDP-Xyl to GlcA-Xyl-GlcA (Homo sapiens)
Functional status

Loss of function of B4GAT1:LARGE mutants [Golgi membrane]

Normal Entity
Disease Entity
Status
Disease
Authored
Jassal, B  (2015-06-30)
Reviewed
Hansen, L  (2015-12-18)
Joshi, HJ  (2015-12-18)
Created
Jassal, B  (2015-06-30)
Cite Us!